Clinical Personalized Medicine for Parkinson's Disease and Implications on Sleep Dysfunction

Personalized medicine (PM) for Parkinson's disease (PD) can range from precision genomic therapies such as ambroxol in glucocerebrosidase mutation-linked PD to treatment tailored for sleep dysfunction in nonmotor subtypes of PD. Additionally, in future pharmacogenetics may also play a part by i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Sleep medicine clinics Jg. 20; H. 3; S. 417
Hauptverfasser:	Metta, Vinod, Popławska-Domaszewicz, Karolina, Chen, Rosabel, Chaudhuri, K Ray
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.09.2025
Schlagworte:	Humans Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson Disease - genetics Parkinson Disease - therapy Precision Medicine - methods Sleep Wake Disorders - drug therapy Sleep Wake Disorders - etiology Sleep Wake Disorders - therapy Pharmacogenetics Sleep dysfunction Precision medicine Genomic medicine Insomnia pharmacogenetics Personalised medicine Subtype Parkinson’s disease
ISSN:	1556-4088
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!